After doing some DD, agree with your logic. Took a decent position (25k) last few days between 1.00 and 1.05. There is a small downside to maybe .90 if everyone that bought the two days after it tanked (1.25-1.65) decides to panic/ and or get frustrated an sell. Realistically, it should go back to... More
GTHP's biophotonics scan will replace 60M annual PAP smear tests.
It's more accurate and produces instant test results.
Market cap only $30M !!!!!!!!! !!!!!!!!! !!!!!!!!
Get in BEFORE it takes off.
I wouldn't be looking for a buck anytime soon. Eyes of biotech investors from around the world got opened a little today wrt PBMD and that group of investors made a statement today - that seemed to say - This little ''down under'' biotech company has gotten very undervalued - given its prospects......in their collective opinion.
The move was based on pure speculation, absolutely baseless, and the reversal will be sharp.
"12:55 PM EST, 11/25/2013 (MT Newswires) -- Shares of Prima BioMed Ltd. (PBMD) soared Monday, after the Australian biotech company's chief executive, Matthew Lehman, made a presentation on the company's prospective cancer vaccine at an industry conference in London.
A company spokeswoman said there wasn't any new information presented at the conference. "All material information has been presented previously in our press releases," said the spokeswoman, Jessica Brown, via email.
Still, investors appeared more enthusiastic about the vaccine's prospects following the presentation. "
I did like it at $1 per share, almost bought in last week, but it will get there again this week, or soon enough.